DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Kappos L, Calabresi P, O’Connor P et al.
Efficacy and safety of ocrelizumab in patients with relapsing remitting multiple sclerosis: results of a phase II randomised placebo-controlled multicentre trial.
Multiple Sclerosis 2010;
16: S33
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.